Profile Summary

Medical qualification: M. D. (Internal Medicine) Speciality training in Medical Oncology and BMT at Tata Memorial Hospital, Parel, Mumbai.

Designation: Director, BMT & Academics, Consultant Medical Oncology and BMT physician

Years of experience: 24 years

Areas of expertise:

  • Medical Oncologist and Bone Marrow / Stem Cell Transplant Specialist
  • All solid tumours /Malignancies (Carcinoma Breast, Ovary, Lung)
  • Hematolymphoid Malignancies (Multiple Myeloma, AML, ALL, Lymphoma, Hodgkin’s Lymphoma)
  • Allogeneic Stem Cell Transplantation (Matched Sibling)
  • Haplo matched Stem Cel Transplantation
  • Matched Unrelated Stem Cell Transplantation
  • Autologous Stem Cell Transplantation for Lymphoma, Non-Hodgkin’s Lymphoma, Multiple Myeloma
  • Immunotherapy

 

Introduction:

Dr Reetu Jain comes with an experience of over 25 years. She leads the department of Bone Marroaw Transplant. The department under her lead has performed nearly 600 Bone Marrow Transplants which is highest in Maharashtra. Her team has achieved successful transplants for patients of several hematological disorders like thalassemia, aplastic anemia,Sickle cell anaemia,fanconi’s anemia to malignant diseases including Leukemias, lymphomas,multiple myeloma,neuroblastoma,Germ cell tumor and sarcomas. Our patient survival rates are at par with the national and international centers

She has several national & international publications to her credits and is eminent member of various globally recognized associations.

Awards & Publications : 

  AWARDS:

  • Received 2nd prize for Best Clinical presentation in Hospital Grand Rounds in August 2002 at   Tata Memorial Hospital.
  • JAN 2020 :  Best  Premium Poster : “Autologous stem cell transplant in Multiple myeloma : A decade Long ,Single centre experience. “ Jan 2020, Third Indian Myeloma Congress 2020,Hyderabad

PUBLICATIONS:   National: 19 & International: 08  

National Publications:

  • Parikh P.M, Jain Reetu:”Out-patient Management of BMT patient after discharge”.Medicine Update.(The Association of Physicians of India )Vol 12,2002,1074-80.
  • P.S.R.K. Sastry, A Sainani, C. Bakshi, R. Agrawal, S. H. Adavani: Father and son with Hodgkin’s Disease – A Case report: India and & Medical & Pediatric Oncology net 26; No 2005
  • Jain Reetu,Advani S.H,Sainani A, Bakshi C, Sastry P.S.RK:Caspofungin :The first Echinocandin antifungal drug.”Bulletin of the Jaslok Hospital and Research Centre.Vol XXVIII No 2,2003;33-37.
  • Bakshi C A,RA Jain,P.S.R.k Sastry,AR Sainani,S H Advani:Imatinib in Gastrointestinal Stromal Tumours.JAPI vol .52,2004;403-409.
  • Jain R,C Bakshi,Sastry P.S.R.k,A.Sainani,Advani S.H:Supraventrcular Tachycadia in a patient on Trastuzumab:A case report. Indian Journal of Medical and Pediatric oncology. Vol. 26; 2 June 2005;S0-S2
  • Jain R,C Bakshi,Sastry P.S.R.k,A.Sainani,AdvaniS.H: Objective Response with Geftinib in Non-Small cell (NSCLC) Lung cancer.:A report of two patients with review of literature. Indian Journal of Medical and Pediatric Oncology.(IJMPO). Vol 26;  2 June 2005 49-50
  • Jain Reetu:  Newer  Strategies in overcoming drug resistance in Chronic Myeloid Leukemia .CML News Letter. Vol 2  2008, 5-10.
  • Prathamesh Joshi, Vikram Lele, Reetu Jain1,Shaila Khubchandani2,:  Stomach  metastasis of breast carcinoma mimicking  primary gastric neoplasm on fluorodeoxy glucose–positron emission tomography–computed tomography.sthis Indian Journal of Medical and Paediatric Oncology | Apr-Jun 2013 | Vol 34 | Issue 2
  • ”Engraftment Syndrome following Hematopoietic stem cell transplant: A retrospective review of 70 cases.” Journal of Clinical Oncology  (33) e 18010-e18010  May 2015
  • “Efficacy of plerixafor with GCSF for mobilization of PBSC: A single center experience. Journal of clinical Oncology (33) (15-suppl)” :e 18011-e18011  May 2015
  • Reetu Jain, Ganapathi Bhat M, Vasu Babu, Rajas Patel: Loss of Human Epidermal Growth Factor Receptor 2 (HER-2) Expression after Trastuzumab Treatment in Locally Advanced Breast Cancer : Case  report
  • Annuals of international medical and dental research, Volume 3, Issue 6, Page 1-3, September 2017
  • Reetu Jain ,S H Advani, Vasu Babu Goli, Ganapathi Bhat,Anjana Sainani: Monoclonal Gammopathy in Chronic Lymphocytic Leukemia: A case report and review of its literature (Indian  Journal of Medical and  Paediatric Oncology, volume XX, Issue XX,Page 1-3, 2017)
  • Reetu Jain, Vasu Babu, Ganapathi Bhat, Anjana Sainani, S. H. Advani : Musculoskeletal chronic graft versus host disease – A rare complication of allogeneic hematopoietic stem cell transplantation : A case report and review of its literature. The South Asian Journal of Cancer Volume 6 Issue 4 Page 150-151, Oct-Dec 2017
  • V. Sheth, A. Gore, R. Jain, A. Ghanekar, T. Saikia: Pegfilgrastim: More Cost Effective and Equally Efficacious Option as Compared to Filgrastim in Autologous Stem Cell Transplant. Indian Journal of Medical and Paediatric Oncology (May 2018)
  • Pegfilgrastim: More Cost Effective and Equally Efficacious Option as Compared to Filgrastim in Autologous Stem Cell Transplant.Indian Journal of Hematolgy and Blood transfusion .Jan 2019,Vol 35 ,1, pp66-71
  • Vipul sheth ,Reetu Jain ,AGore, A.Ghanekar, Saikia T: Preemptive and upfront plerixafor: Safe and effective strategy for patients undergoing autologous stem cell transplant and at high risk for mobilization failure.” Indian Journal of Medical and Paediatric Oncology IJMPO 41(1):19 January 2020
  • Editorial commentary :” Midst of COVID-19 Crisis – Lookout for One Another to Practice Humanity!” .  Indian Journal of Medical and Paediatric Oncology | Volume 41 | Issue 4 | July-August 2020
  • Gautam Zaveri, Reetu Jain, Nishank Mehta, Bhavuk garg : An Overview of Decision Making in the Management of Metastatic Spinal Tumors: Indian Journal of Orthopaedics, ,1-16  Mar 2021
  • Ganapathi Bhat,  Reetu Jain, Samir S. Shah , Fahad Afzal Shaikh: Relapsed Plasmablastic Lymphoma in an HIV-Infected Patient—Experience of High-Dose Chemotherapy with Autologous Stem Cell Rescue: A Case Report with Review of Literature .Indian Journal of Medical and Pediatric Oncology  .Mar 2022

 

International publications:

 

  • Jain Reetu,Advani S.H: Special aspects of Management of lymphomas in  developing countries. International textbook of lymphoid Neoplasm Edition 3.Ed  Ian Magrath.  Jan 2008.
  • Comparison of Toxicity and Outcomes of BCNU-Containing Conditioning Regimens Vs LACE in Lymphoma Transplants: A Retrospective Multicenter Analysis November 2011 Blood 118 (21) :2023-2023
  • The Etiology of Pleural Effusions Develping During Dasatinib Therapy in CML Could Be Variable: Need for Awareness and Investigations. Blood  2012 ,120(21):4456-4456
  • Pre-Transplant Consolidation and Cost Effectiveness of RIC Allogeneic SCT in Patients of AML-CR1 in India.  (Blood 2014 124:2462)
  • Pre-Transplant Consolidation and Cost Effectiveness of RIC Allogeneic SCT in Patients of AML-CR1 in India (Biology of blood and Marrow transplantation . 21(2): S298 Feb 2015
  • LACE versus BEAM conditioning in relapsed and refractory lymphoma transplant: retrospective multicenter analysis of toxicity and efficacy (International  Journal Of Hematology (103) 3:  Mar 2016)   
  • HSCT Guidelines for Transplant Practices During the COVID-19 Pandemic in India [ISBMT DOCUMENT Version1.0] volume 2 (2020) 3 59-70 : Blood cell therapy  2020 ( APBMT)
  • Clinical Benefit of Comprehensive Genomic Profiling for Advanced Cancers in India -Journal of Clinical Oncology ( JCO) April 2022, 1-8

Memberships

  • Life member Association of Medical Consultants (AMC).
  • Mumbai Hematology Group (MHG)
  • Indian Medical Association (IMA)
  • Life Member Bone Marrow Donor Registry (India).
  • Life Member Indian Cooperative Oncology Network (ICON)
  • Life Member Indain Oncology Study Group ( IOSG)
  • Indian Society of stem cell transplant ( ISBMT)   
  • Member Asia Pacific Bone Marrow Transplant  group  (APBMT)
  • Member American Society of Bone Marrow Transplant (ASCTCT)
  • Life Member Indian Society of Medical & Pediatric Oncology (ISMPO)
  • Member European Society of Medical Oncology (ESMO)
  • Life Member Indian society of Immuno-Oncology (ISO)